BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Lin Z, Zhang B, Guo L, Liu S, Li H, Zhang J, Ye Q. β-elemene sensitizes hepatocellular carcinoma cells to oxaliplatin by preventing oxaliplatin-induced degradation of copper transporter 1. Sci Rep 2016;6:21010. [PMID: 26867799 DOI: 10.1038/srep21010] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Chung SW, Cho YS, Choi JU, Kim HR, Won TH, Kim SY, Byun Y. Highly potent monomethyl auristatin E prodrug activated by caspase-3 for the chemoradiotherapy of triple-negative breast cancer. Biomaterials 2019;192:109-17. [PMID: 30447398 DOI: 10.1016/j.biomaterials.2018.11.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
2 An S, Jang E, Lee JH. Preclinical Evidence of Curcuma longa and Its Noncurcuminoid Constituents against Hepatobiliary Diseases: A Review. Evid Based Complement Alternat Med 2020;2020:8761435. [PMID: 32802138 DOI: 10.1155/2020/8761435] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Wu D, Lv D, Zhang T, Guo L, Ma F, Zhang C, Lv G, Huang L. Antitumor effects of β-elemene via targeting the phosphorylation of insulin receptor. Endocr Relat Cancer 2019;26:187-99. [PMID: 30422809 DOI: 10.1530/ERC-18-0370] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mishra M, Jayal P, Karande AA, Chandra N. Identification of a co-target for enhancing efficacy of sorafenib in HCC through a quantitative modeling approach. FEBS J 2018;285:3977-92. [PMID: 30136368 DOI: 10.1111/febs.14641] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu J, Tang X, Shi Y, Ma C, Zhang H, Zhang J, Lu Y, Wei J, Li L, Han L. β-Elemene suppresses hepatocellular carcinoma cell growth via mediating LncRNA HOTAIR / SP1 / PDK1 axis impact of β-elemene on hepatocellular carcinoma cells growth. J Ethnopharmacol 2021;:114456. [PMID: 34333105 DOI: 10.1016/j.jep.2021.114456] [Reference Citation Analysis]
6 Ambrož M, Matoušková P, Skarka A, Zajdlová M, Žáková K, Skálová L. The Effects of Selected Sesquiterpenes from Myrica rubra Essential Oil on the Efficacy of Doxorubicin in Sensitive and Resistant Cancer Cell Lines. Molecules 2017;22:E1021. [PMID: 28632185 DOI: 10.3390/molecules22061021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
7 Zhai B, Zeng Y, Zeng Z, Zhang N, Li C, Zeng Y, You Y, Wang S, Chen X, Sui X, Xie T. Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy. Int J Nanomedicine 2018;13:6279-96. [PMID: 30349250 DOI: 10.2147/IJN.S174527] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
8 Yong L, Ma Y, Liang C, He G, Zhao Z, Yang C, Hai B, Pan X, Liu Z, Liu X. Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1. Phytotherapy Research 2019;33:1837-50. [DOI: 10.1002/ptr.6373] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
9 Jiang Z, Jacob JA, Loganathachetti DS, Nainangu P, Chen B. β-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect. Front Pharmacol 2017;8:105. [PMID: 28337141 DOI: 10.3389/fphar.2017.00105] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
10 Wang S, Zhang C, Li Y, Li P, Zhang D, Li C. Anti-liver cancer effect and the mechanism of arsenic sulfide in vitro and in vivo. Cancer Chemother Pharmacol 2019;83:519-30. [PMID: 30542770 DOI: 10.1007/s00280-018-3755-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
11 Zheng F, Tang Q, Zheng XH, Wu J, Huang H, Zhang H, Hann SS. Inactivation of Stat3 and crosstalk of miRNA155-5p and FOXO3a contribute to the induction of IGFBP1 expression by beta-elemene in human lung cancer. Exp Mol Med 2018;50:1-14. [PMID: 30209296 DOI: 10.1038/s12276-018-0146-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
12 Oria VO, Bronsert P, Thomsen AR, Föll MC, Zamboglou C, Hannibal L, Behringer S, Biniossek ML, Schreiber C, Grosu AL, Bolm L, Rades D, Keck T, Werner M, Wellner UF, Schilling O. Proteome Profiling of Primary Pancreatic Ductal Adenocarcinomas Undergoing Additive Chemoradiation Link ALDH1A1 to Early Local Recurrence and Chemoradiation Resistance. Transl Oncol 2018;11:1307-22. [PMID: 30172883 DOI: 10.1016/j.tranon.2018.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
13 Katanaev VL, Blagodatski A, Xu J, Khotimchenko Y, Koval A. Mining Natural Compounds to Target WNT Signaling: Land and Sea Tales. Handb Exp Pharmacol 2021;269:215-48. [PMID: 34455487 DOI: 10.1007/164_2021_530] [Reference Citation Analysis]
14 Cardoso BA, Ramos TL, Belo H, Vilas-Boas F, Real C, Almeida AM. Vorinostat synergizes with antioxidant therapy to target myeloproliferative neoplasms. Exp Hematol 2019;72:60-71.e11. [PMID: 30769020 DOI: 10.1016/j.exphem.2019.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Guo Z, Liu Z, Yue H, Wang J. Beta-elemene increases chemosensitivity to 5-fluorouracil through down-regulating microRNA-191 expression in colorectal carcinoma cells. J Cell Biochem. 2018;119:7032-7039. [PMID: 29737579 DOI: 10.1002/jcb.26914] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
16 Cheng H, Ge X, Zhuo S, Gao Y, Zhu B, Zhang J, Shang W, Xu D, Ge W, Shi L. β-Elemene Synergizes With Gefitinib to Inhibit Stem-Like Phenotypes and Progression of Lung Cancer via Down-Regulating EZH2. Front Pharmacol 2018;9:1413. [PMID: 30555330 DOI: 10.3389/fphar.2018.01413] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
17 Alonso-Peña M, Espinosa-Escudero RA, Soto-Muñiz M, Sanchon-Sanchez P, Sanchez-Martin A, Marin JJ. Role of transportome in the pharmacogenomics of hepatocellular carcinoma and hepatobiliary cancer. Pharmacogenomics 2019;20:957-70. [PMID: 31486734 DOI: 10.2217/pgs-2019-0033] [Reference Citation Analysis]
18 Tan T, Li J, Luo R, Wang R, Yin L, Liu M, Zeng Y, Zeng Z, Xie T. Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review. Molecules 2021;26:5792. [PMID: 34641334 DOI: 10.3390/molecules26195792] [Reference Citation Analysis]
19 Zhou J, Kang Y, Chen L, Wang H, Liu J, Zeng S, Yu L. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. Front Pharmacol. 2020;11:343. [PMID: 32265714 DOI: 10.3389/fphar.2020.00343] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 18.5] [Reference Citation Analysis]
20 Besse A, Besse L, Kraus M, Mendez-Lopez M, Bader J, Xin BT, de Bruin G, Maurits E, Overkleeft HS, Driessen C. Proteasome Inhibition in Multiple Myeloma: Head-to-Head Comparison of Currently Available Proteasome Inhibitors. Cell Chem Biol 2019;26:340-351.e3. [PMID: 30612952 DOI: 10.1016/j.chembiol.2018.11.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
21 Liu YP, Zheng CC, Huang YN, He ML, Xu WW, Li B. Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment. MedComm (2020) 2021;2:315-40. [PMID: 34766149 DOI: 10.1002/mco2.55] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sagwal SK, Pasqual-Melo G, Bodnar Y, Gandhirajan RK, Bekeschus S. Combination of chemotherapy and physical plasma elicits melanoma cell death via upregulation of SLC22A16. Cell Death Dis 2018;9:1179. [PMID: 30518936 DOI: 10.1038/s41419-018-1221-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 11.5] [Reference Citation Analysis]
23 Amerigos Daddy J C K, Chen M, Raza F, Xiao Y, Su Z, Ping Q. Co-Encapsulation of Mitoxantrone and β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia. Pharmaceutics 2020;12:E191. [PMID: 32102214 DOI: 10.3390/pharmaceutics12020191] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Gan D, He W, Yin H, Gou X. β-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway. Oncol Lett 2020;19:291-300. [PMID: 31897141 DOI: 10.3892/ol.2019.11103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
25 Zhai B, Zhang N, Han X, Li Q, Zhang M, Chen X, Li G, Zhang R, Chen P, Wang W, Li C, Xiang Y, Liu S, Duan T, Lou J, Xie T, Sui X. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review. Biomed Pharmacother 2019;114:108812. [PMID: 30965237 DOI: 10.1016/j.biopha.2019.108812] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 10.3] [Reference Citation Analysis]
26 Herr R, Halbach S, Heizmann M, Busch H, Boerries M, Brummer T. BRAF inhibition upregulates a variety of receptor tyrosine kinases and their downstream effector Gab2 in colorectal cancer cell lines. Oncogene 2018;37:1576-93. [PMID: 29326440 DOI: 10.1038/s41388-017-0063-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
27 Jianxin C, Qingxia X, Junhui W, Qinhong Z. A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine. Integr Cancer Ther 2017;16:597-604. [PMID: 27444311 DOI: 10.1177/1534735416660617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
28 Riley RS, O'Sullivan RK, Potocny AM, Rosenthal J, Day ES. Evaluating Nanoshells and a Potent Biladiene Photosensitizer for Dual Photothermal and Photodynamic Therapy of Triple Negative Breast Cancer Cells. Nanomaterials (Basel) 2018;8:E658. [PMID: 30149630 DOI: 10.3390/nano8090658] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
29 Fliefel R, El Ashwah A, Entekhabi S, Kumbrink J, Ehrenfeld M, Otto S. Bifunctional effect of Zoledronic Acid (ZA) on human mesenchymal stem cells (hMSCs) based on the concentration level. J Stomatol Oral Maxillofac Surg 2020;121:634-41. [PMID: 32171967 DOI: 10.1016/j.jormas.2020.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Alqudah MA, Al-ashwal FY, Alzoubi KH, Alkhatatbeh M, Khabour O. Vitamin E protects human lymphocytes from genotoxicity induced by oxaliplatin. Drug and Chemical Toxicology 2018;41:281-6. [DOI: 10.1080/01480545.2017.1384835] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
31 Xu L, Guo T, Qu X, Hu X, Zhang Y, Che X, Song H, Gong J, Ma R, Li C, Fan Y, Ma Y, Hou K, Wu P, Dong H, Liu Y. β-elemene increases the sensitivity of gastric cancer cells to TRAIL by promoting the formation of DISC in lipid rafts. Cell Biol Int 2018;42:1377-85. [PMID: 29957841 DOI: 10.1002/cbin.11023] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
32 Bai Z, Yao C, Zhu J, Xie Y, Ye XY, Bai R, Xie T. Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification. Molecules 2021;26:1499. [PMID: 33801899 DOI: 10.3390/molecules26061499] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Gao T, Liao W, Lin L, Zhu Z, Lu M, Fu C, Xie T. Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications. Phytomedicine 2022;102:154090. [DOI: 10.1016/j.phymed.2022.154090] [Reference Citation Analysis]
34 Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers (Basel) 2020;12:E1985. [PMID: 32708138 DOI: 10.3390/cancers12071985] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
35 Zhu J, Li B, Ji Y, Zhu L, Zhu Y, Zhao H. β‑elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A‑VEGFA pathway based on network pharmacology. Oncol Rep 2019;42:2561-71. [PMID: 31638231 DOI: 10.3892/or.2019.7360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
36 Althurwi HN, Abdel-Kader MS, Alharthy KM, Salkini MA, Albaqami FF. Cymbopogon Proximus Essential Oil Protects Rats against Isoproterenol-Induced Cardiac Hypertrophy and Fibrosis. Molecules 2020;25:E1786. [PMID: 32295062 DOI: 10.3390/molecules25081786] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Chen Y, Zhu Z, Chen J, Zheng Y, Limsila B, Lu M, Gao T, Yang Q, Fu C, Liao W. Terpenoids from Curcumae Rhizoma: Their anticancer effects and clinical uses on combination and versus drug therapies. Biomed Pharmacother 2021;138:111350. [PMID: 33721752 DOI: 10.1016/j.biopha.2021.111350] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
38 Yang L, Wang H, Lu W, Yang G, Lin Z, Chen R, Li H. Quantitative proteomic analysis of oxaliplatin induced peripheral neurotoxicity. J Proteomics 2022;266:104682. [PMID: 35830924 DOI: 10.1016/j.jprot.2022.104682] [Reference Citation Analysis]
39 Zhang LY, Zhang JG, Yang X, Cai MH, Zhang CW, Hu ZM. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery. Curr Top Med Chem 2020;20:2789-800. [PMID: 33076809 DOI: 10.2174/1568026620666201019111524] [Reference Citation Analysis]
40 Chung SW, Kim GC, Kweon S, Lee H, Choi JU, Mahmud F, Chang HW, Kim JW, Son W, Kim SY, Byun Y. Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment. Biomaterials 2018;182:35-43. [DOI: 10.1016/j.biomaterials.2018.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
41 Chang Z, Gao M, Zhang W, Song L, Jia Y, Qin Y. Beta-elemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinoma. Surg Oncol 2017;26:333-7. [PMID: 29113648 DOI: 10.1016/j.suronc.2017.07.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
42 Wiedmer T, Blank A, Pantasis S, Normand L, Bill R, Krebs P, Tschan MP, Marinoni I, Perren A. Autophagy Inhibition Improves Sunitinib Efficacy in Pancreatic Neuroendocrine Tumors via a Lysosome-dependent Mechanism. Mol Cancer Ther 2017;16:2502-15. [PMID: 28729403 DOI: 10.1158/1535-7163.MCT-17-0136] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 7.8] [Reference Citation Analysis]
43 Wang X, Liu Z, Sui X, Wu Q, Wang J, Xu C. Elemene injection as adjunctive treatment to platinum-based chemotherapy in patients with stage III/IV non-small cell lung cancer: A meta-analysis following the PRISMA guidelines. Phytomedicine 2019;59:152787. [PMID: 31005810 DOI: 10.1016/j.phymed.2018.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
44 Ahmed K, Koval A, Xu J, Bodmer A, Katanaev VL. Towards the first targeted therapy for triple-negative breast cancer: Repositioning of clofazimine as a chemotherapy-compatible selective Wnt pathway inhibitor. Cancer Lett 2019;449:45-55. [PMID: 30771433 DOI: 10.1016/j.canlet.2019.02.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
45 Abo El-Nasr NME, Saleh DO, Mahmoud SS, Nofal SM, Abdelsalam RM, Safar MM, El-Abhar HS. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur J Pharmacol 2020;874:173010. [PMID: 32067934 DOI: 10.1016/j.ejphar.2020.173010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
46 Scott GK, Yau C, Becker BC, Khateeb S, Mahoney S, Jensen MB, Hann B, Cowen BJ, Pegan SD, Benz CC. Targeting Mitochondrial Proline Dehydrogenase with a Suicide Inhibitor to Exploit Synthetic Lethal Interactions with p53 Upregulation and Glutaminase Inhibition. Mol Cancer Ther 2019;18:1374-85. [PMID: 31189611 DOI: 10.1158/1535-7163.MCT-18-1323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
47 Hu D, Gao J, Yang X, Liang Y. A Comprehensive Mini-Review of Curcumae Radix: Ethnopharmacology, Phytochemistry, and Pharmacology. Natural Product Communications 2021;16:1934578X2110206. [DOI: 10.1177/1934578x211020628] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Awais M, Aizaz A, Nazneen A, Bhatti QUA, Akhtar M, Wadood A, Atiq Ur Rehman M. A Review on the Recent Advancements on Therapeutic Effects of Ions in the Physiological Environments. Prosthesis 2022;4:263-316. [DOI: 10.3390/prosthesis4020026] [Reference Citation Analysis]
49 Abu-Izneid T, Rauf A, Shariati MA, Khalil AA, Imran M, Rebezov M, Uddin MS, Mahomoodally MF, Rengasamy KRR. Sesquiterpenes and their derivatives-natural anticancer compounds: An update. Pharmacol Res 2020;161:105165. [PMID: 32835868 DOI: 10.1016/j.phrs.2020.105165] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]